Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer.
PubWeight™: 0.81‹?›
Published in Mol Oncol on June 10, 2014
Authors
Teodoro Vargas1, Juan Moreno-Rubio2, Jesús Herranz1, Paloma Cejas3, Susana Molina1, Margarita González-Vallinas1, Ricardo Ramos4, Emilio Burgos5, Cristina Aguayo6, Ana B Custodio6, Guillermo Reglero7, Jaime Feliu6, Ana Ramírez de Molina8
Author Affiliations
1: IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain.
2: Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain; Medical Oncology, Infanta Sofía University Hospital, Madrid, Spain.
3: Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain.
4: Genomic Service, Scientific Park of Madrid, Madrid, Spain.
5: Pathology Department, La Paz University Hospital (IdiPAZ), Madrid, Spain.
6: Medical Oncology, La Paz University Hospital (IdiPAZ), Madrid, Spain.
7: IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain; Food Research Institute (CIAL) CEI UAM+CSIC, Madrid, Spain.
8: IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain. Electronic address: aramirez@iib.uam.es.
Articles by these authors ⇆